Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2026)

Fulgent Genetics (FLGT) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $81.7 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 151.84% year-over-year to $81.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $260.3 million (down 9.25% YoY) and the FY2025 annual result came in at $211.0 million, down 39.68% from the prior year.
• Change in Acquisitions & Divestments rose to $81.7 million in Q1 2026 per FLGT's latest filing, from $78.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $141.4 million in Q1 2023, with the low at $27.8 million in Q1 2022.
• Average Change in Acquisitions & Divestments over 5 years is $81.4 million, with a median of $78.1 million recorded in 2025.
• Year-over-year, Change in Acquisitions & Divestments soared 409.39% in 2023 and slumped 66.01% in 2025.
• Fulgent Genetics' Change in Acquisitions & Divestments stood at $100.8 million in 2022, then jumped by 30.6% to $131.7 million in 2023, then sank by 45.48% to $71.8 million in 2024, then grew by 8.79% to $78.1 million in 2025, then increased by 4.63% to $81.7 million in 2026.
• Business Quant data shows FLGT's Change in Acquisitions & Divestments at $81.7 million in Q1 2026, $78.1 million in Q4 2025, and $40.2 million in Q3 2025.